Brown NJ - Search Results

1

A population-based study in Ghana to investigate inter-individual variation in plasma t-PA and PAI-1.

Williams SM, Stocki S, Jiang L, Brew K, Gordon S, Vaughan DE, Brown NJ, Poku KA, Moore JH. Williams SM, et al. Among authors: brown nj. Ethn Dis. 2007 Summer;17(3):492-7. Ethn Dis. 2007. PMID: 17985503

2

Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin.

Brown NJ, Nadeau JH, Vaughan DE. Brown NJ, et al. Thromb Haemost. 1997 Mar;77(3):522-5. Thromb Haemost. 1997. PMID: 9066005 Clinical Trial.

3

Angiotensin-converting enzyme inhibitors.

Brown NJ, Vaughan DE. Brown NJ, et al. Circulation. 1998 Apr 14;97(14):1411-20. doi: 10.1161/01.cir.97.14.1411. Circulation. 1998. PMID: 9577953 Review.

4

Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.

Stein CM, Brown N, Vaughan DE, Lang CC, Wood AJ. Stein CM, et al. J Am Coll Cardiol. 1998 Jul;32(1):117-22. doi: 10.1016/s0735-1097(98)00210-1. J Am Coll Cardiol. 1998. PMID: 9669258 Free article.

5

Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.

Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE. Brown NJ, et al. Hypertension. 1998 Dec;32(6):965-71. doi: 10.1161/01.hyp.32.6.965. Hypertension. 1998. PMID: 9856958 Clinical Trial.

6

Bradykinin stimulates tissue plasminogen activator release in human vasculature.

Brown NJ, Gainer JV, Stein CM, Vaughan DE. Brown NJ, et al. Hypertension. 1999 Jun;33(6):1431-5. doi: 10.1161/01.hyp.33.6.1431. Hypertension. 1999. PMID: 10373228

7

Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.

Brown NJ, Agirbasli M, Vaughan DE. Brown NJ, et al. Hypertension. 1999 Aug;34(2):285-90. doi: 10.1161/01.hyp.34.2.285. Hypertension. 1999. PMID: 10454455

8

Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.

Brown NJ, Kim KS, Chen YQ, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE. Brown NJ, et al. J Clin Endocrinol Metab. 2000 Jan;85(1):336-44. doi: 10.1210/jcem.85.1.6305. J Clin Endocrinol Metab. 2000. PMID: 10634408 Clinical Trial.

9

Prothrombotic effects of angiotensin.

Brown NJ, Vaughan DE. Brown NJ, et al. Adv Intern Med. 2000;45:419-29. Adv Intern Med. 2000. PMID: 10635057 Review.

10

Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.

Vaughan DE, Brown NJ. Vaughan DE, et al. Among authors: brown nj. Circulation. 2000 Aug 8;102(6):E43. doi: 10.1161/01.cir.102.6.e43. Circulation. 2000. PMID: 10931820 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

862 results

Search Page

Filters